Continuous ambulatory peritoneal dialysis in Egypt: progression despite handicaps.
BACKGROUND
Despite the well-known advantages of continuous ambulatory peritoneal dialysis (CAPD), it continues to be grossly underutilized in many developing countries. However, some developing countries, such as Mexico, use the modality very effectively. In view of this, we started the first CAPD program in Egypt.


METHODS
Since its start in 1997, our program has treated 33 patients. Straight double-cuffed Tenckhoff catheters were surgically placed in all patients. Twin-bag systems were used. All patients underwent monthly clinical and biochemical assessment and measurement of Kt/V urea. Peritonitis and exit-site infection rates were monitored.


RESULTS
Most treated patients were adult and female. Mean age was 31.7 years and mean follow-up duration was 18 months. Peritonitis rate was 1 episode /21.3 months and was easily managed in most patients. Staphylococcus aureus was the most commonly isolated organism (24%) but 49% of cases were culture negative. There were no exit-site infections. Mean weekly Kt/V urea was 1.78 +/- 0.23.


CONCLUSIONS
We report the successful development of a small CAPD program in Egypt, made possible by well-established financial support, a motivated team of doctors and nurses, and good patient selection and training.
Mahmoud
Khaled M
KM
Urology and Nephrology Center, Mansoura University, Mansoura, Egypt. khaledmahmoud2000@hotmail.com
Sheashaa
Hussein A
HA
Gheith
Osama A
OA
Wafa
Ehab W
EW
Agroudy
Amgad E
AE
Sabry
Alaa A
AA
Abbas
Tarek M
TM
Hamdy
Ahmed F
AF
Rashad
Rashad H
RH
Sobh
Mohamed A
MA
D000328:Adult; D006233:Persons with Disabilities; D004534:Egypt / Q000453:epidemiology; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000628:therapy*; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000706:statistics & numerical data*; D010538:Peritonitis / Q000453:epidemiology / Q000382:microbiology; D013203:Staphylococcal Infections / Q000382:microbiology; D013211:Staphylococcus aureus / Q000302:isolation & purification